Delay discounting of reward and caudate nucleus volume in individuals with α-synuclein gene duplication before and after the development of Parkinson's disease

Neurodegenerative Diseases

Volumn 11, Issue 2, 2012, Pages 72-78

  Szamosi, Andŕs ^a   Nagy, Helga ^b,c   Kéri, Szabolcs ^a,d  

^a National Psychiatry Center   (Hungary)

^b National Institute for Medical Rehabilitation   (Hungary)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^d UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Synuclein; Caudate nucleus; Delay discounting; Impulsivity; Parkinson's disease; Reward

Indexed keywords

LEVODOPA;

ADULT; ALPHA SYNUCLEIN GENE; ARTICLE; BRAIN CORTEX; BRAIN CORTEX ATROPHY; BRAIN SIZE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE; GENE DUPLICATION; HUMAN; IMPULSIVENESS; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE;

ADULT; ALPHA-SYNUCLEIN; ANTIPARKINSON AGENTS; CAUDATE NUCLEUS; CEREBRAL CORTEX; DECISION MAKING; DOPAMINE; FEMALE; FOLLOW-UP STUDIES; GENE DUPLICATION; HUMANS; LEVODOPA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; REACTION TIME; REWARD;

EID: 84870058722     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000341997     Document Type: Article

References (39)

1. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, et al: Alpha-synuclein locus triplication causes Parkinson's disease. Science 2003; 302: 841.
2. Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, et al: Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004; 364: 1167-1169.
3. Ahn TB, Kim SY, Kim JY, Park SS, Lee DS, Min HJ, et al: Alpha-synuclein gene duplication is present in sporadic Parkinson disease. Neurology 2008; 70: 43-49.
4. Ross OA, Braithwaite AT, Skipper LM, Kachergus J, Hulihan MM, Middleton FA, et al: Genomic investigation of alpha-synuclein multiplication and parkinsonism. Ann Neurol 2008; 63: 743-750.
5. Onoda K, Okamoto Y, Kunisato Y, Aoyama S, Shishida K, Okada G, et al: Expanding the clinical phenotype of SNCA duplication carriers. Mov Disord 2009; 24: 1811-1819.
6. Nemani VM, Lu W, Berge V, Nakamura K, Onoa B, Lee MK, et al: Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 2010; 65: 66-79.
7. Lundblad M, Decressac M, Mattsson B, Björklund A: Impaired neurotransmission caused by overexpression of-synuclein in nigral dopamine neurons. Proc Natl Acad Sci USA 2012; 109: 3213-3219.
8. Yavich L, Oksman M, Tanila H, Kerokoski P, Hiltunen M, van Groen T, et al: Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein. Neurobiol Dis 2005; 20: 303-313.
9. Oksman M, Tanila H, Yavich L: Brain reward in the absence of alpha-synuclein. Neuroreport 2006; 17: 1191-1194.
10. Kéri S, Moustafa AA, Myers CE, Benedek G, Gluck MA:-Synuclein gene duplication impairs reward learning. Proc Natl Acad Sci USA 2010; 107: 15992-15994.
11. Kirby KN, Petry NM, Bickel WK: Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen 1999; 128: 78-87.
12. Ainslie G: Specious reward: a behavioral theory of impulsiveness and impulse control. Psychol Bull 1975; 82: 463-496.
13. Hoffman WF, Schwartz DL, Huckans MS, McFarland BH, Meiri G, Stevens AA, Mitchell SH: Cortical activation during delay discounting in abstinent methamphetamine dependent individuals. Psychopharmacology (Berl) 2008; 201: 183-193.
14. Marco-Pallarés J, Mohammadi B, Samii A, Münte TF: Brain activations reflect individual discount rates in intertemporal choice. Brain Res 2010; 1320: 123-129.
15. Paloyelis Y, Asherson P, Mehta MA, Faraone SV, Kuntsi J: DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls. Neuropsychopharmacology 2010; 35: 2414-2426.
16. Schweighofer N, Yamaguchi S, Doya K, Yamawaki S: Inter-individual discount factor differences in reward prediction are topographically associated with caudate activation. Exp Brain Res 2011; 212: 593-601.
17. Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
18. Lang AE, Fahn S: Assessment of Parkinson's disease; in Munsat TL (ed): Quantification of Neurologic Deficit. Boston, Butterworth-Heinemann. 1989, pp 285-309.
19. Hoehn M, Yahr M: Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-442.
20. Voon V, Fox SH: Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 2007; 64: 1089-1096.
21. Weintraub D, Nirenberg M: Impulse control and related disorders in Parkinson's disease. Neurodegener Dis DOI: 10.1159/000341996.
22. Folstein MF, Folstein SE, McHugh PR: 'Mini-Mental State'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
23. Green L, Myerson J: A discounting framework for choice with delayed and probabilistic rewards. Psychol Bull 2004; 130: 769-792.
24. Fischl B, Salat DH, van der Kouwe AJ, Makris N, Ségonne F, Quinn BT, Dale AM: Sequence-independent segmentation of magnetic resonance images. Neuroimage 2004; 23(suppl 1):S69-S84.
25. Segonne F, Dale AM, Busa E, Glessner M, Salat D, Hahn HK, Fischl B: A hybrid approach to the skull stripping problem in MRI. Neuroimage 2004; 22: 1060-1075.
26. Housden CR, O'Sullivan SS, Joyce EM, Lees AJ, Roiser JP: Intact reward learning but elevated delay discounting in Parkinson's disease patients with impulsive-compulsive spectrum behaviors. Neuropsychopharmacology 2010; 35: 2155-2164.
27. Messina D, Cerasa A, Condino F, Arabia G, Novellino F, Nicoletti G, et al: Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Parkinsonism Relat Disord 2011; 17: 172-176.
28. Schrag A, Good CD, Miszkiel K, Morris HR, Mathias CJ, Lees AJ, Quinn NP: Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000; 54: 697-702.
29. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC: Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations. Mov Disord 2006; 21: 989-996.
30. Quattrone A, Nicoletti G, Messina D, Fera F, Condino F, Pugliese P, et al: MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 2008; 246: 214-221.
31. Lee SH, Kim SS, Tae WS, Lee SY, Choi JW, Koh SB, Kwon DY: Regional volume analysis of the Parkinson disease brain in early disease stage: gray matter, white matter, striatum, and thalamus. AJNR Am J Neuroradiol 2011; 32: 682-687.
32. Ibarretxe-Bilbao N, Tolosa E, Junque C, Marti MJ: MRI and cognitive impairment in Parkinson's disease. Mov Disord 2009; 24 (suppl 2):S748-S753.
33. Glenn AL, Raine A, Yaralian PS, Yang Y: Increased volume of the striatum in psychopathic individuals. Biol Psychiatry 2010; 67: 52-58.
34. Voelbel GT, Bates ME, Buckman JF, Pandina G, Hendren RL: Caudate nucleus volume and cognitive performance: are they related in childhood psychopathology? Biol Psychiatry 2006; 60: 942-950.
35. Ersche KD, Barnes A, Jones PS, Morein-Zamir S, Robbins TW, Bullmore ET: Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence. Brain 2011; 134: 2013-2024.
36. Schultz W: Behavioral theories and the neurophysiology of reward. Annu Rev Psychol 2006; 57: 87-115.
37. Vekrellis K, Xilouri M, Emmanouilidou E, Rideout HJ, Stefanis L: Pathological roles of-synuclein in neurological disorders. Lancet Neurol 2011; 10: 1015-1025.
38. Hinault MP, Farina-Henriquez-Cuendet A, Goloubinoff P: Molecular chaperone and associated cellular clearance mechanisms against toxic protein conformers in Parkinson's disease. Neurodegener Dis 2011; 8: 397-412.
39. Kéri S, Nagy H, Myers CE, Benedek G, Shohamy D, Gluck MA: Risk and protective haplotypes of the alpha-synuclein gene associated with Parkinson's disease differentially affect cognitive sequence learning. Genes Brain Behav 2008; 7: 31-36.